cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Mind Medicine Mindmed Inc
48 own
76 watching
Current Price
$0
$-0.09
(-2.68%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
135.93M
52-Week High
52-Week High
19.95
52-Week Low
52-Week Low
2.12
Average Volume
Average Volume
0.1M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization135.93M
icon52-Week High19.95
icon52-Week Low2.12
iconAverage Volume0.1M
iconDividend Yield--
iconP/E Ratio--
What does the Mind Medicine Mindmed Inc do?
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.
Read More
How much money does Mind Medicine Mindmed Inc make?
News & Events about Mind Medicine Mindmed Inc.
Benzinga
28days ago
Clinical-stage biopharma company Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) has reported its unaudited financial results for the quarter ended March 31, 2023, and shared the periods business highlights. Numbers show: read more...
Globe Newswire
28days ago
MindMed Board has Presided over Botched Regulatory Strategies, Outsized Expenses, Soaring Executive Compensation, and Value Destructive Financings FCMs Four Highly Qualified Director Nominees to Bring Desperately Needed Accountability, Expertise, and Fresh Shareholder Focused Perspective to the ...
Globe Newswire
1month ago
Meaningful Change is Needed at MindMed After Years of Poor Performance FCMs Candidates Have Decades of Relevant Industry Experience and are Laser Focused on Bringing MM-120 to Market FCM to Provide Detailed Operational Plan to Address MindMeds Operational Challenges SHERIDAN, Wyo., April 21, 2023 (...
Business Wire
1month ago
Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the Company or MindMed), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, announced today that Prof. Matthias Liechti and Dr. Felix Mueller, MindMed collaborators at University Hospital...
Zolmax
3 months ago
Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD Get Rating) have received a consensus rating of Buy from the nine ratings firms that are currently covering the company, MarketBeat.com reports. Six research analysts have rated the stock with a buy rating. The average 12 month price target among ...
Frequently Asked Questions
Frequently Asked Questions
What is Mind Medicine Mindmed Inc share price today?
plus_minus_icon
Can Indians buy Mind Medicine Mindmed Inc shares?
plus_minus_icon
How can I buy Mind Medicine Mindmed Inc shares from India?
plus_minus_icon
Can Fractional shares of Mind Medicine Mindmed Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Mind Medicine Mindmed Inc stocks?
plus_minus_icon
What is today’s traded volume of Mind Medicine Mindmed Inc?
plus_minus_icon
What is today’s market capitalisation of Mind Medicine Mindmed Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Mind Medicine Mindmed Inc?
plus_minus_icon
What percentage is Mind Medicine Mindmed Inc down from its 52-Week High?
plus_minus_icon
What percentage is Mind Medicine Mindmed Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.09
(-2.68%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00